Vertex Pharmaceuticals Inc
Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –
Vertex Pharmaceuticals Alpine Immune Sciences — Total assets by Quarter
Alpine Immune Sciences — Total assets ($M) ($M)
Vertex Pharmaceuticals Alpine Immune Sciences — Total assets: $374M in Q1 2024, up 42.6% from a year earlier. No newer figure appears in the documents we track.
Where the Q1 2024 figure comes from
Source: SEC Filing ↗
Reported in SEC XBRL (CIK 0001626199 Alpine Immune Sciences).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Alpine Immune Sciences — Total assets ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q1 2024 | Mar 31, 2024 | 374 | +42.6% | SEC Filing ↗ |
| Q4 2023 | Dec 31, 2023 | 380 | +32.5% | SEC Filing ↗ |
| Q3 2023 | Sep 30, 2023 | 241 | -17.5% | SEC Filing ↗ |
| Q2 2023 | Jun 30, 2023 | 253 | +17.1% | SEC Filing ↗ |
| Q1 2023 | Mar 31, 2023 | 262 | +12.0% | SEC Filing ↗ |
| Q4 2022 | Dec 31, 2022 | 287 | +12.0% | SEC Filing ↗ |
| Q3 2022 | Sep 30, 2022 | 292 | +24.9% | SEC Filing ↗ |
| Q2 2022 | Jun 30, 2022 | 216 | +35.0% | SEC Filing ↗ |
| Q1 2022 | Mar 31, 2022 | 234 | +80.0% | SEC Filing ↗ |
| Q4 2021 | Dec 31, 2021 | 256 | +77.6% | SEC Filing ↗ |
| Q3 2021 | Sep 30, 2021 | 233 | +51.6% | SEC Filing ↗ |
| Q2 2021 | Jun 30, 2021 | 160 | +55.6% | SEC Filing ↗ |
| Q1 2021 | Mar 31, 2021 | 130 | +160.7% | SEC Filing ↗ |
| Q4 2020 | Dec 31, 2020 | 144 | +166.4% | SEC Filing ↗ |
| Q3 2020 | Sep 30, 2020 | 154 | +137.9% | SEC Filing ↗ |
| Q2 2020 | Jun 30, 2020 | 103 | +46.5% | SEC Filing ↗ |
| Q1 2020 | Mar 31, 2020 | 49.9 | -25.7% | SEC Filing ↗ |
| Q4 2019 | Dec 31, 2019 | 54.1 | -1.4% | SEC Filing ↗ |
| Q3 2019 | Sep 30, 2019 | 64.7 | +0.4% | SEC Filing ↗ |
| Q2 2019 | Jun 30, 2019 | 70.1 | -4.1% | SEC Filing ↗ |
| Q1 2019 | Mar 31, 2019 | 67.1 | -16.8% | SEC Filing ↗ |
| Q4 2018 | Dec 31, 2018 | 54.9 | – | SEC Filing ↗ |
| Q3 2018 | Sep 30, 2018 | 64.5 | – | SEC Filing ↗ |
| Q2 2018 | Jun 30, 2018 | 73.1 | – | SEC Filing ↗ |
| Q1 2018 | Mar 31, 2018 | 80.7 | – | SEC Filing ↗ |
Cite this data
StockData. (2026). Vertex Pharmaceuticals Alpine Immune Sciences — Total assets ($M), quarterly Q1 2018–Q1 2024 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/alpine-assets
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.